Scientists found genes that help cancer cells to penetrate the brain

August 11, 2020

An international team of scientists, including a researcher from Sechenov University, reviewed scientific articles on proteins (and genes encoding them) that help cancer cells enter the brain. An understanding of the processes that facilitate the formation of metastases in the brain will allow scientists to create new methods for cancer diagnosis and treatment. Details of the study can be found in the journal Trends in Cancer.

Brain tissues are very sensitive to changes in the levels of many substances and to the penetration of microorganisms and immune cells, but they need a large amount of nutrients and oxygen. Satisfying the needs of the brain requires a dense network of thin blood vessels, covered with a special shell that lets in essential substances and blocks all other compounds and cells. This shell, consisting of adjacent endothelial cells tightly connected to each other by special proteins, forms the blood-brain barrier (BBB), which prevents the free exchange of substances between blood vessels and brain tissues.

BBB works very well (letting in less than 2% of the molecules), but it is still not perfect: cancer cells sometimes manage to slip through it and trigger the development of metastases; since many drugs cannot get into the brain, this significantly complicates cancer treatment and worsens the prognosis for patients with metastases. The authors of the article decided to find out which genes give cancer cells such a 'superpower'.

'Metastasis formation is controlled by proteins and genes encoding these proteins. The purpose of this work was to systematise experimentally or clinically proven findings about the proteins and microRNAs that allow migration of tumour cells to the brain. It turned out that their production is typical for a number of metastases, while most of the cell molecules described in literature are unique for a particular type of tumour. Thus, the possibility of regulating genes that stimulate the migration of tumour cells to the brain may be a challenge faced by doctors in reducing the formation of intracerebral metastases in the future,' said Ilya Ulasov, one of the authors, a leading researcher at the Institute of Regenerative Medicine, Sechenov University.

Tumour cells are known to enter the brain both through dense contacts between the cells of the tunicae (layers of the blood vessels) and through these cells themselves. In the first case, cancer cells use enzymes and/or microRNAs to disrupt the structure of the dense contacts and increase the permeability of the BBB.

One of these enzymes is cathepsin C: it destroys the proteins of the dense contacts, and its inhibitors (substances that slow down its action) can suppress the growth of metastases in breast cancer. Two other enzymes - seprase and urokinase-type plasminogen activator - have shown similar effects in melanoma, and some metalloproteinases may be possible targets for anti-cancer therapy. Another protein, placental growth factor, triggers a chain of reactions to facilitate the development of metastases in lung, gastric or colorectal cancer.

MicroRNAs enable communication between cancer cells and their environment, including BBB cells and proteins. For example, miR-105 affects ZO-1 protein, contributing to the formation of metastases in breast cancer, while miR-143-3p can enhance BBB permeability in lung cancer.

The second way - penetration of cancer cells through BBB cells - is possible due to proteins of the cell wall, integrins, and certain groups of enzymes. In several types of cancer, metastasis cells showed an increased content of integrins avβ3 and avβ8. It is possible that they are involved in the formation of metastases in the brain and can serve as a biomarker of the disease. Another integrin, VLA-4, is produced in the metastases of most melanoma patients and promotes the binding of cancer cells and BBB cells, which opens the way to the brain.

In total, the authors reviewed 44 proteins, described the mechanism of their influence on the formation of metastases and listed the genes encoding them. The study will help scientists work out new ways to prevent and treat cancer, stroke and Alzheimer's disease, which also affect BBB integrity.
-end-


Sechenov University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.